RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BERTETTO O
Collezione AOU San Luigi di Orbassano

Items : 9

Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer. in JAMA network open / JAMA Netw Open. 2023 Oct 2;6(10):e2338039. doi: 10.1001/jamanetworkopen.2023.38039.

2023
ASL Cuneo 2
ASL Asti
AOU Alessandria
AO Cuneo
ASL Alessandria
ASL Torino 3
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Bollito E; Gontero P; Porpiglia F; Galassi C; Bertetto O; Zitella A; Zaramella S; Zarrelli G; Stancati S; Surleti D; Varvello F; Volpe A; Squeo MS; Ponti di Sant'Angelo F; Ruggiero L; Ruo Redda MG; Serao A; Muto G; Migliari R; Molinaro L; Montefiore F; Moroni M; Montefusco G; Guercio S; Garibaldi E; Girelli G; Griffa D; Dalmasso E; Di Stasio A; et alii...

How uro-oncology has been affected by COVID-19 emergency? Data from Piedmont/Valle d'Aosta Oncological Network, Italy. in Urologia / Urologia. 2021 Feb;88(1):3-8. doi: 10.1177/0391560320946186.

2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Bertetto O; Volpe A; Oderda G; Porpiglia F; Muto G; Falcone M; Fasolis G; Calleris G; Gontero P; Oderda M;

Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e. in Clinical and translational radiation oncology / Clin Transl Radiat Oncol. 2018 Jun 11;11:33-39. doi: 10.1016/j.ctro.2018.06.002. eCollection 2018 Ju

2018
ASL Asti
AOU Alessandria
ASL VCO
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pozzi G; Fiandra C; Ragona R; Bertetto O; Ricardi U; Bona C; Tseroni V; Verna R; Ruo Redda MG; Piva C; Moretto F; Martini S; Iorio GC; Trino E; Gallio E; Arcadipane F; Franco P;

Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network. in BMC cancer / BMC Cancer. 2009 Nov 3;9:388. doi: 10.1186/1471-2407-9-388.

2009
AOU San Luigi di Orbassano

Brizzi MP; Berruti A; Ferrero A; Milanesi E; Volante M; Castiglione F; Birocco N; Bombaci S; Perroni D; Ferretti B; Alabiso O; Ciuffreda L; Bertetto O; Papotti M; Dogliotti L;

Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial. in European urology / Eur Urol. 2007 Jul;52(1):134-41. doi: 10.1016/j.eururo.2006.12.029. Epub 2006 Dec 26.

2007
AOU San Luigi di Orbassano

Dogliotti L; Cartenì G; Siena S; Bertetto O; Martoni A; Bono A; Amadori D; Onat H; Marini L;

Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up. in Urologic oncology / Urol Oncol. 2005 Jan-Feb;23(1):1-7. doi: 10.1016/j.urolonc.2004.06.003.

2005
AOU San Luigi di Orbassano

Berruti A; Fara E; Tucci M; Tarabuzzi R; Mosca A; Terrone C; Gorzegno G; Fasolis G; Tampellini M; Porpiglia F; De Stefanis M; Fontana D; Bertetto O; Dogliotti L;

Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2005 Jan;41(2):249-55. doi: 10.1016/j.ejca.2004.07.003.

2005
AOU San Luigi di Orbassano

Berruti A; Bitossi R; Bottini A; Bonardi S; Donadio M; Nigro C; Bertetto O; Danese S; Bertone E; Sarobba MG; Farris A; Katsaros D; Castiglione F; Volpe T; Lattuada S; Mancarella S; Dogliotti L;

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines. in British journal of cancer / Br J Cancer. 2005 Feb 28;92(4):634-8. doi: 10.1038/sj.bjc.6602335.

2005
AOU San Luigi di Orbassano

Berruti A; Bitossi R; Gorzegno G; Bottini A; Generali D; Milani M; Katsaros D; Rigault de la Longrais IA; Bellino R; Donadio M; Ardine M; Bertetto O; Danese S; Sarobba MG; Farris A; Lorusso V; Dogliotti L;

Combination chemotherapy with carboplatin and methotrexate in the treatment of advanced urothelial carcinoma. A phase II study. in American journal of clinical oncology / Am J Clin Oncol. 1995 Feb;18(1):78-82. doi: 10.1097/00000421-199502000-00017.

1995
AOU San Luigi di Orbassano

Dogliotti L; Bertetto O; Berruti A; Clerico M; Fanchini L; Sicora W; Faggiuolo R;